Ann: Kyocera completes Progenza Due Diligence, page-15

yes bioqld and also Kyocera s position as a typical large Japanese conglomerate is this:
> they want to engage in health and choose this area of regenerative medicine which is part of a long term govt stimulus legislation (all well published.. the japanese shortcut to market etc)
> all large jap conglomerates choose an area of health and see this as part of their a social responsibility .. which is also why they look so deeply into the IP/solidity and take their time.. in case they join they will be committed long term..
> Leo has fixed what was basically wrong with this company using his own money/network (RGS was run by a scientist from the backseat with puppets as CEO/Chair instead of a commercial mind from the industry being involved..all other founders/scientists got pushed out ..)
> Leo has the right current focus/agenda post that decade of draining sh funds for science only and we should back him